Crystalline forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-BETA, DELTA-dihydroxy-5-(1-methylethyl)-3-Phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)
A Standard patent application filed on 21 May 2002 credited to Park, Aeri ; Coates, David, Andrew ; Morrison, Henry, Grant, II ; Li, Zheng, Jane ; Gushurst, Karen, Sue ; Vlahova, Petinka Ivanova ; Byrn, Stephen, Robert ; Krzyzaniak, Joseph, Francis

Details

Application number :

2002258092  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Crystalline forms of [R-(R*,R*)]-2-(4-Fluorophenyl)-BETA, DELTA-dihydroxy-5-(1-methylethyl)-3-Phenyl-4-[phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin)  

Inventor :

Park, Aeri ; Coates, David, Andrew ; Morrison, Henry, Grant, II ; Li, Zheng, Jane ; Gushurst, Karen, Sue ; Vlahova, Petinka Ivanova ; Byrn, Stephen, Robert ; Krzyzaniak, Joseph, Francis  

Agent name :

Shelston IP  

Address for service :

Level 21 60 Margaret Street Sydney NSW 2000 Australia  

Filing date :

21 May 2002  

Associated companies :

 

Applicant name :

Warner-Lambert Company LLC  

Applicant address :

201 Tabor Road Morris Plains NJ 07950 United States of America  

Old name :

 

Original Source :

Go